A Brief History of Things That Were Safe Until They Weren’t

TFRi maintains this timeline not as an argument by analogy. The fact that asbestos was once considered safe does not prove that electromagnetic radiation is dangerous. The fact that lead paint was marketed to children does not mean that cell phones harm children. Argument by analogy is logically invalid, and TFRi does not employ it. This timeline serves a different purpose: it demonstrates that the statement “currently considered safe by regulatory authorities” is a statement about the current state of regulatory assessment, not about physical reality. The historical record shows, repeatedly, that these two things are not always the same. Whether they are currently the same for electromagnetic radiation is the question that TFRi exists to keep open.

The Timeline

Radium (1898-1938): Marie Curie discovered radium in 1898. By the 1910s, radium was a consumer product: radium water (Radithor), radium chocolate, radium suppositories, radium-dial watches, radium toothpaste. The Radium Girls — factory workers who painted watch dials with radium paint — were assured the material was safe. Many developed radiation necrosis of the jaw. Eben Byers, a wealthy socialite who drank Radithor daily on medical advice, died in 1932 with his jaw disintegrating. The Wall Street Journal headline: “The Radium Water Worked Fine Until His Jaw Came Off.” Radium consumer products were not banned until 1938.

Lead paint (1900s-1978): Lead-based paint was marketed for residential use for over seven decades, including with advertisements specifically targeting families with children. The Dutch Boy Paint mascot — a child — was used to sell lead paint for children’s rooms. The toxicity of lead was known since antiquity (Vitruvius warned against lead water pipes in the 1st century BCE), but the paint industry successfully lobbied against regulation for decades. The Lead Industries Association funded research designed to attribute childhood lead poisoning to negligent parents rather than toxic products. The United States banned lead paint for residential use in 1978 — decades after the neurotoxicity was scientifically established.

Asbestos (1900s-1989): Asbestos was used in insulation, brake linings, roofing, and hundreds of other products throughout the 20th century. The first medical documentation of asbestosis (lung scarring from asbestos fiber inhalation) was published in 1906. Internal documents from Johns-Manville and other manufacturers, revealed in litigation decades later, show that the asbestos industry knew of the health risks by the 1930s and suppressed the evidence. The EPA did not ban most asbestos uses until 1989 — over eighty years after the first medical documentation of harm.

Tobacco (1950s-1998): The statistical link between smoking and lung cancer was established by Doll and Hill in 1950 and confirmed by the U.S. Surgeon General’s report in 1964. The tobacco industry responded not with product modification but with a deliberate strategy of manufacturing scientific doubt — funding research designed to produce ambiguous results, promoting “controversy” where scientific consensus existed, and attacking the credibility of researchers who published adverse findings. The strategy, documented in internal industry documents released in litigation (the “Tobacco Documents”), succeeded in delaying regulatory action by decades.

DDT (1939-1972): Dichlorodiphenyltrichloroethane was introduced as a miracle insecticide in 1939 and used globally for decades. Its discoverer, Paul Hermann Müller, received the Nobel Prize in 1948. Rachel Carson’s Silent Spring (1962) documented DDT’s environmental persistence and bioaccumulation. The chemical industry responded with a campaign to discredit Carson — attacks that included questioning her mental health and her qualifications. DDT was banned in the U.S. in 1972, thirty-three years after its introduction.

Thalidomide (1957-1961): Thalidomide was marketed as a safe sedative for pregnant women. It caused severe birth defects in over 10,000 children worldwide before it was withdrawn. The disaster led to the 1962 Kefauver-Harris Amendment requiring proof of drug safety before marketing — a regulatory standard that did not previously exist.

The Pattern

The pattern across these cases is consistent: a substance or exposure is introduced, declared safe by the regulatory framework of the time, and widely adopted. Evidence of harm accumulates — sometimes over years, sometimes over decades. The industry producing the substance responds not by modifying the product but by challenging the evidence: funding counter-research, manufacturing doubt, attacking the credibility of researchers, and lobbying against regulation. Regulatory action eventually occurs — but with a delay measured in decades between the establishment of evidence and the implementation of protection.

In every case, the regulatory delay is explained after the fact as the reasonable time required for scientific certainty. In every case, internal industry documents (when they become available through litigation) reveal that the producing industry was aware of the risks earlier than the regulatory timeline suggests, and that the delay was at least partially manufactured.